Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

705
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
705
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

86.4K
Overview
86.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Academic-industry collaboration in biomedical innovation: A multi-model review of barriers and facilitators.

Drug discovery today·2025
Same author

Diabetes screening in dialysis populations with a glucose challenge test and continuous glucose monitoring-DIGEST study.

Diabetes, obesity & metabolism·2025
Same author

Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector.

Stem cell research & therapy·2025
Same author

Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept.

Journal of medical virology·2024
Same author

The SElf-Care After REnal Transplantation Study: A Retrospective Evaluation of a Home-Monitoring Program Implemented as Standard Care.

Transplant international : official journal of the European Society for Organ Transplantation·2024
Same author

Ten Years of Quality Monitoring of Abdominal Organ Procurement in the Netherlands and Its Impact on Transplant Outcome.

Transplant international : official journal of the European Society for Organ Transplantation·2024

Related Experiment Video

Updated: Apr 2, 2026

Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

14.8K

Transplanting the elderly: Balancing aging with histocompatibility.

G J Dreyer1, A C Hemke2, M E J Reinders1

  • 1Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.

Transplantation Reviews (Orlando, Fla.)
|September 29, 2015
PubMed
Summary

The Eurotransplant Senior DR-compatible Program (ESDP) aims to improve kidney transplants for older adults by reintroducing HLA-DR matching. This aims to reduce rejection and improve survival in elderly patients with end-stage renal disease.

More Related Videos

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

12.5K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K

Related Experiment Videos

Last Updated: Apr 2, 2026

Isolation and Transplantation of Different Aged Murine Thymic Grafts.
05:47

Isolation and Transplantation of Different Aged Murine Thymic Grafts.

Published on: May 13, 2015

14.8K
Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

12.5K
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

16.1K

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Geriatric Medicine

Background:

  • Global increase in the elderly population, with over 25% projected by 2050.
  • 48% of end-stage renal disease (ESRD) patients were aged 65+ in 2012.
  • Kidney transplantation is preferred over dialysis for ESRD, with good outcomes in selected elderly patients.

Purpose of the Study:

  • To address organ scarcity and long wait times for elderly ESRD patients.
  • To improve transplant success rates and quality of life for older recipients.
  • To evaluate the impact of the Eurotransplant Senior DR-compatible Program (ESDP).

Main Methods:

  • Analysis of kidney transplant outcomes in elderly patients.
  • Implementation of dedicated allocation systems like the Eurotransplant Senior Program (ESP).
  • Introduction of the Eurotransplant Senior DR-compatible Program (ESDP) with HLA-DR matching.

Main Results:

  • Previous allocation systems (ESP) led to increased acute rejections and immunosuppression.
  • Death with a functioning graft and infectious diseases are leading causes of graft loss in elderly recipients.
  • The ESDP was designed to improve transplant outcomes by re-introducing HLA-DR matching.

Conclusions:

  • The ESDP aims to enhance the success of kidney transplantation in the elderly.
  • Re-introducing HLA-DR matching may improve graft survival and patient quality of life.
  • Optimizing allocation strategies is crucial for elderly ESRD patients awaiting transplantation.